New Studies Highlight Performance of Vectra Test in Patients with Rheumatoid Arthritis Who Were Treated with Tofacitinib and Rituximab
Medical Device Investing Precision Therapeutics Projects Meaningful STREAMWAY System Sales in Europe in the Second Half of 2018
HTG Molecular Diagnostics and Firalis Announce an Agreement Enabling Firalis’ Commercialization of Theranostic and Research Products and Services Based on HTG EdgeSeq Technology
Pharmaceutical Investing Precision Therapeutics Signs Letter of Intent to Purchase Remainder of Helomics Corporation Shares
3D Signatures and l’Institut Universitaire de Cardiologie et de Pneumologie de Québec Announce Collaboration
Precision Therapeutics Forms TumorGenesis Inc. Subsidiary to Focus on the Next Generation of Patient Derived Tumor Models
Myriad’s myRisk® Hereditary Cancer Test Finds More Than 12 Percent of Men with Prostate Cancer Carry an Inherited Genetic Mutation
